Wojciech Szubert

No ORCID on file · 5 papers in corpus · active 2018-2020

Study types

  • article 4
  • letter 1

Condition tags

  • chronic_pelvic_pain 5
  • dysmenorrhea 2
  • dyspareunia 1
article 2020
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

article 2020
Randomised controlled trial of gabapentin for chronic pelvic pain in women

Background Chronic pelvic pain (CPP) affects 2-24% of women worldwide and evidence for medical treatments is limited. Gabapentin is effective in treating some chronic pain conditions. We aimed to determine the efficacy and safety of gabapen…

letter 2018
45% of UK gynaecologists think chronic pelvic pain is managed badly
·doi:10.1016/j.ejogrb.2018.03.014
article 2018
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
·doi:10.60692/6nvwt-mjd92

Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and treatment is …

article 2018
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
·doi:10.1136/bmjopen-2016-014924

INTRODUCTION: Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and…